On December 2, 2024, CVS Health announced cash tender offers for its 4.100% Senior Notes due 2025 and other series of notes, including those issued by Aetna. The total purchase price for these offers will not exceed $2 billion, excluding accrued interest. The tender offers aim to retire a portion of CVS Health's outstanding debt.The Any and All Notes tender offer expires on December 6, 2024, while the Maximum Tender Offer Notes have an early tender date of December 13, 2024, and a final expiration date of December 31, 2024. CVS Health plans to fund these offers with proceeds from new subordinated debt securities.Barclays Capital Inc. and Mizuho Securities USA LLC are acting as Dealer Managers for the tender offers, with D.F. King & Co., Inc. as the Tender and Information Agent.

On December 2, 2024, CVS Health announced cash tender offers for its 4.100% Senior Notes due 2025 and other series of notes, including those issued by Aetna. The total purchase price for these offers will not exceed $2 billion, excluding accrued interest. The tender offers aim to retire a portion of CVS Health's outstanding debt.The Any and All Notes tender offer expires on December 6, 2024, while the Maximum Tender Offer Notes have an early tender date of December 13, 2024, and a final expiration date of December 31, 2024. CVS Health plans to fund these offers with proceeds from new subordinated debt securities.Barclays Capital Inc. and Mizuho Securities USA LLC are acting as Dealer Managers for the tender offers, with D.F. King & Co., Inc. as the Tender and Information Agent.